AOD-9604 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-11-23. Where a claim depends on a specific study, the study is described rather than over-claimed.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
== Membership == In 1975, chairman Frank Zeidler claimed that SPUSA had around 500 members nationwide. SPUSA saw growth during the late 1970s and early to mid-1980s, expanding from around 600 members to around 1,700 members. In 2008, WMNF claimed that SPUSA had around 3,000 members. However, in 2010, CommonDreams wrote that SPUSA had only 1,000 members, and party members described that as an increase in membership. In May 2011, The New York Times stated that SPUSA had "about 1,000 members nationally". In February 2012, The Root stated that SPUSA had "around 1,500" members.
=== Odor === Salts of strong acids and strong bases ("strong salts") are non-volatile and often odorless, whereas salts of either weak acids or weak bases ("weak salts") may smell like the conjugate acid (e.g., acetates like acetic acid (vinegar) and cyanides like hydrogen cyanide (almonds)) or the conjugate base (e.g., ammonium salts like ammonia) of the component ions. That slow, partial decomposition is usually accelerated by the presence of water, since hydrolysis is the other half of the reversible reaction equation of formation of weak salts.
=== Defense towers === The porte d’Italie was guarded by two towers built to the east of the previous towers of the 4th century BC. The north tower or square tower, 10.50 m (34.4 ft) wide, is attached to the Wall of Crinas. Some internal blocks bear the marks of quarrymen or stonemasons. The south tower is also called the leaning tower, because its eastern facing has collapsed, the ground being formerly marshy. It was also square, 10.30 m (33.8 ft) wide. Only the eastern facing is preserved. It has two loopholes. These two towers, which rose to a height of 12 to 15 meters (39 to 49 ft), framed the porte d’Italie. A 22 m-long (72 ft) curtain wall connected the leaning tower to a rectangular tower (7.8 m × 8.4 m [26 ft × 28 ft]). This curtain wall has been rebuilt to give a better idea of this fortification.
The β and γ phases are obtained by annealing the most stable α-Al2S3 phase at several hundred degrees Celsius. Compressing aluminum sulfide to 2–65 bar results in the δ phase where vacancies are arranged in a superlattice of tetragonal symmetry. Unlike Al2O3, in which the Al(III) centers occupy octahedral holes, the more expanded framework of Al2S3 stabilizes the Al(III) centers into one third of the tetrahedral holes of a hexagonally close-packed arrangement of the sulfide anions. At higher temperature, the Al(III) centers become randomized to give a "defect wurtzite" structure. And at still higher temperatures stabilize the γ-Al2S3 forms, with a structure akin to γ-Al2O3. Molecular derivatives of Al2S3 are not known. Mixed Al-S-Cl compounds are however known. Al2Se3 and Al2Te3 are also known.
== Questionable techniques == Some forensic techniques, believed to be scientifically sound at the time they were used, have turned out later to have much less scientific merit or none. Some such techniques include:
Sources: en.wikipedia.org
==== Dark Messiah of Might and Magic (2006) and cancelled projects ==== Antonov joined French developer Arkane Studios. He was a level designer for their 2006 action role-playing game (RPG) Dark Messiah of Might And Magic, helping his team replicate Valve's process of making levels for Half-Life 2. Around 2007 and 2008, Arkane began developing an officially licensed Half-Life sequel, centered around the alien zombies that infest the ghost town of Ravenholm in Half-Life 2. Antonov continued helping Arkane replicate Valve's design process. The project was soon scrapped, because they did not develop it in the time that Valve wanted, and Valve was having trouble deciding where Half-Life as a series should go while making its episodic entries. Arkane's then-president Raphaël Colantonio has said that Antonov's work on the project "was pivotal to what would become Arkane later", as "he trained us in all of [Valve's] practices in terms of art, in terms of how to think of a level, [and] how to think of architecture". Antonov was a level designer for the studio's next project, an FPS titled The Crossing, for which he created a sci-fi version of Paris. In 2009, this project was also cancelled, as Arkane was unable to secure financing for it, as well as a publisher that would let them retain the game's intellectual property rights in the future. However, elements of The Crossing later came to fruition in Arkane's 2021 FPS Deathloop.
== Discovery == Delta-sleep-inducing peptide was first discovered in 1974 by the Swiss Schoenenberger-Monnier group who isolated it from the cerebral venous blood of rabbits in an induced state of sleep. It was primarily believed to be involved in sleep regulation due to its apparent ability to induce slow-wave sleep in rabbits, but studies on the subject have been contradictory. DSIP-like material has been found in human breast milk.
=== Forms of chipotle === Chipotles are purchased in numerous forms: chipotle powder, chipotle flakes, chipotle pods, canned chipotles in adobo sauce, concentrated chipotle base, and wet chipotle meat marinade. Canned adobo sauce is the most common form in the United States of America, though its marinade or food preservative form originated in Spain. The marinade typically contains various spices, herbs, and vegetables, including tomatoes, onions, powdered dried chilis, garlic, and vinegar. Chipocludo, a term for preserving chipotles practiced in Central Mexico, refers to conservation in a jar of brown sugar and vinegar marinade. En adobo or chipotles adobado are denominations for seasoned canned chipotles in sauce.
Micronutrients are essential chemicals required by organisms in small quantities to perform various biogeochemical processes and regulate physiological functions of cells and organs. By enabling these processes, micronutrients support the health of organisms throughout life. For humans, micronutrients typically take one of three forms: vitamins, trace elements, and dietary minerals. Human micronutrient requirements are in amounts generally less than 100 milligrams per day, whereas macronutrients are required in gram quantities daily. Deficiencies in micronutrient intake commonly result in malnutrition. In ecosystems, micronutrients most commonly take the form of trace elements such as iron, strontium, and manganese. Micronutrient abundance in the environment greatly influences biogeochemical cycles at the microbial level which large ecological communities rely on to survive. For example, marine primary producers (also known as phytoplankton) are reliant upon bioavailable dissolved iron for photosynthesis. Secondary and tertiary producers in oceans are therefore also reliant on the presence of sufficient dissolved iron concentrations. Naturally, micronutrients are transferred between reservoirs through processes like fluvial transport, aeolian processes, ocean circulation, volcanism, and biological uptake/transfer. Anthropogenic activities also alter the abundance of micronutrients in ecosystems.
Sources: en.wikipedia.org
But Geoffrey Pullum, the coiner of the term snowclone, considers that it is only a "lexical word-formation analog". Martha Brockenbrough, the founder of The Society for the Promotion of Good Grammar, said that no one should aspire to write with cliches and that although they do help to get a lot of complicated things across in few words, they are not a good way to get people to keep reading what you're writing.
The synthesis of fentanyl and its analogues are illustrated in these skeletal diagrams. The synthesis of fentalogs is done by reacting the ring structure as a base, 4-ANPP also called 4-anilino-N-phenethylpiperidine and despropionylfentanyl. 4-ANPP acts as a base because of its two amine nitrogens, the secondary amine acts as a base to react with an organic acid which condenses into an amide. Depending on the organic acid used in the amide condensation, different analogues of fentanyl will be produced. To help align this phenomenon in the eyes of chemists, we have numerated the precursor 4-ANPP with a [0.], and then the reactions synthesizing fentanyl, acetylfentanyl, butyrylfentanyl, and benzoylfentanyl with a [1.], [2.], [3.], and [4.] respectively. To further aid in the chemical pedagogy we have aligned each number with a reaction number -> precursor -> product system that follows the following scheme: EXAMPLE: reaction number -> precursor -> product [compound name] 1 -> α -> a [fentanyl] 2 -> β -> b [acetylfentanyl] 3 -> γ -> c [butyrylfentanyl] 4 -> δ -> d [benzoylfentanyl] Using the above scheme, a chemist can quickly extrapolate the reactions necessary for other fentanyl analogues with more complex organic acids, such as cyclopropryl fentanyl or cyclopentyl fentanyl, or any other fentanyl analogue derived from a reaction of 4-ANPP with a novel organic acid.
gluconeogenesis (GNG) The chain of metabolic reactions that results in the generation of glucose from some non-carbohydrate carbon substrates, including the glucogenic amino acids. It is one of two primary pathways used by most animals to maintain blood sugar levels (the other being glycogenolysis), especially during periods of fasting, starvation, and intense exercise.
Army divisions, while the ARVN, in the invasion of Laos, had only assigned 2 divisions Under the cover of air strikes flown by the U.S. Air Force and the U.S. Navy, the ARVN advanced 20 miles into Laos and finally took the ruins of the town of Tchepone, which had been heavily bombed by the Americans, but were then pinned down by intense PAVN artillery fire from the hills above, making any further advance impossible. In March, Kissinger sent his deputy Haig to inspect the situation personally, leading him to report that the ARVN officers lacked courage and did not want to fight, making retreat the only option. The retreat, when it began, turned into a rout. Kissinger wrote that Lam Son had fallen "far short of our expectations", which he blamed on bad American planning, poor South Vietnamese tactics and Nixon's leadership style, leading Karnow to write that he blamed "everyone, characteristically, except himself". In late May 1971, Kissinger returned to Paris to fruitlessly meet again with Tho. The North Vietnamese demand that Thiệu step down proved to the main obstacle. Kissinger did not want a repeat of the prolonged bout of political instability that characterized South Vietnam from 1963 to 1967 and believed Thiệu was a force for order. Tho suggested to Kissinger that Americans "stop supporting" Thiệu who was running for reelection in a ballot scheduled for 3 October 1971.
Wallace's patent application was granted in 1953, and after improvements to the aperture and the introduction of a mercury manometer to provide precise control over sample size, the brothers founded Coulter Electronics Inc. in 1958 to market their instruments. The Coulter counter was initially designed for counting red blood cells, but with later modifications it proved effective for counting white blood cells. Coulter counters were widely adopted by medical laboratories. The first analyzer able to produce multiple cell counts simultaneously was the Technicon SMA 4A−7A, released in 1965. It achieved this by partitioning blood samples into two channels: one for counting red and white blood cells and one for measuring hemoglobin. However, the instrument was unreliable and difficult to maintain. In 1968, the Coulter Model S analyzer was released and gained widespread use. Similarly to the Technicon instrument, it used two different reaction chambers, one of which was used for the red cell count, and one of which was used for the white blood cell count and hemoglobin determination. The Model S also determined the mean cell volume using impedance measurements, which allowed the red blood cell indices and hematocrit to be derived. Automated platelet counts were introduced in 1970 with Technicon's Hemalog-8 instrument and were adopted by Coulter's S Plus series analyzers in 1980. After basic cell counting had been automated, the white blood cell differential remained a challenge.
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.